1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KEROS THERAPEUTICS INC
Keros Therapeutics Inc
XNAS: KROS
10.99 -1.00 (-8.34%)
725.4K

XNAS 14 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Keros Therapeutics Inc - KROS - stock price prediction, stock price target, analyst ratings from 8 analysts

Keros Therapeutics Inc has a share price target of US$ 22, revenue growth forecast of -98.5%, and profit growth estimate of -246.6% for FY26, based on top 8 analyst calls.